Emerging Weight-Loss Drug Sparks Gray Market Concerns
By Editor • August 31, 2026 • 1 min read
Retatrutide, an unapproved weight-loss drug, is enticing users like Henry, who switched from Ozempic amid concerns over safety and side effects.
Read moreBy Editor • August 31, 2026 • 1 min read
Retatrutide, an unapproved weight-loss drug, is enticing users like Henry, who switched from Ozempic amid concerns over safety and side effects.
Read moreBy Editor • August 25, 2026 • 2 min read
Medicare's new GLP-1 discount program is leaving many patients like Jeff La Marca, who struggle with severe health conditions, without access to affordable treatment.
Read moreBy Editor • August 24, 2026 • 1 min read
The new diabetes pill Foundayo launches in UK pharmacies, providing a weight loss option amid counterfeit concerns.
Read moreBy Editor • August 20, 2026 • 1 min read
John Goodman’s weight loss sparks debate over body image and the perception of weight loss methods in society.
Read moreBy Editor • August 18, 2026 • 1 min read
Enveda reveals early results for lac-phe, an oral drug that aims to mimic exercise benefits while managing weight loss and muscle preservation.
Read moreBy Editor • August 17, 2026 • 2 min read
Anne Hathaway's recent comments on body scrutiny reflect a growing societal obsession with women's appearances, impacting both personal and professional realms.
Read moreBy Editor • August 15, 2026 • 1 min read
A new analysis reveals that high costs of GLP-1 weight-loss drugs create financial burdens, benefiting only those with significant incomes.
Read moreBy Editor • June 5, 2025 • 1 min read
The podcast "Camp Shame" unveils troubling realities of Camp Shane, exposing exploitation and fatphobia in its weight-loss programs for children.
Read moreBy Editor • May 8, 2025 • 2 min read
Jennifer lost 40 pounds in four months using the Simple app, which offers personalized nutrition advice through AI, transforming her health and lifestyle.
Read more